Company intelligence

J.P. Morgan

Investment bankingActiveWebsite ↗

Is this your company? Get featured or correct your listing →

We're still building this profile — here is what Pulse has covered.

Latest Pulse

  1. BlossomHill Files for $100M Nasdaq IPO in Cancer DrugsBlossomHill Therapeutics filed for a $100M Nasdaq IPO under ticker BLSM, adding an oncology-focused biotech with $257M in prior funding to a summer pipeline of clinical-stage listings led by J.P. Morgan, Leerink and Guggenheim.→

Coverage Timeline

newest first
  1. Aug 3, 2026IPOBlossomHill Files for $100M Nasdaq IPO in Cancer Drugs$100M IPO target→

All Coverage

IPO

BlossomHill Files for $100M Nasdaq IPO in Cancer Drugs

Illustration for: BlossomHill Files for $100M Nasdaq IPO in Cancer Drugs
IPO$100M IPO target

BlossomHill Files for $100M Nasdaq IPO in Cancer Drugs

BlossomHill Therapeutics filed for a $100M Nasdaq IPO under ticker BLSM, adding an oncology-focused biotech with $257M in prior funding to a summer pipeline of clinical-stage listings led by J.P. Morgan, Leerink and Guggenheim.

Related Companies

Same sector
Barclays